- Stocks
- Healthcare
IMCC
IM Cannabis Corp.
IMCC
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $1.2M
$1.98
▼ -10.00%
P/E
—
Mkt Cap
$1.2M
52-Wk Range
$1.95–$77.10
52-Week Range
$1.95 - $77.10
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 96.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Multi-jurisdictional licensing and operations across three major cannabis markets
- Vertically integrated cultivation and production capabilities
- Established brand portfolio with consumer recognition in medical and recreational segments
- Strategic geographic diversification reducing regulatory and market concentration risk
Bear Case
1 risk
- High volatility (beta 2.1). Larger-than-normal price swings expected.
Growth
Moderate growth ahead
Expanding medical cannabis adoption and prescription rates globally
Value
Valuation data unavailable
Momentum
Falling
-77.7% over 3m
Quality
Stable
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying IMCC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 16, 2026
AUG 13, 2026
Most recent quarter reported revenue of $4.6M. Reported EPS of -$0.28.
Reported EPS · last 4Q
0 of 1 beats
Q3 26
—
Revenue trend · last 8Q
—
—
—
+4%
-14%
-0%
+18%
-50%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$10.8M
$10.2M
$9.8M
$9.2M
$9.3M
$10.2M
$11.5M
$4.6M
Margins · last 8Q
Gross
—
Operating
—
Profit
-26.2%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How IMCC stacks vs Drug Manufacturers - Specialty & Generic
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related